Vascular smooth muscle cell migration signaling (VSMC migration signaling)

Vascular smooth muscle cell (VSMC) migration signaling refers to the complex network of intracellular pathways that govern the movement of smooth muscle cells from the tunica media to the tunica intima of blood vessels. This process is a hallmark of vascular remodeling and plays a critical role in the pathogenesis of atherosclerosis, post-angioplasty restenosis, and pulmonary hypertension (Gerthoffer, 2007, Circulation Research). Under physiological conditions, VSMCs maintain a contractile phenotype; however, in response to vascular injury or inflammatory stimuli (such as PDGF, Angiotensin II, or TGF-beta), they undergo a phenotypic switch to a synthetic, migratory state (Rzucidlo et al., 2007, Journal of Vascular Surgery). This transition involves the activation of various signaling nodes, including Rho-GTPases, Mitogen-Activated Protein Kinases (MAPK), and Phosphoinositide 3-kinase (PI3K), which coordinate actin cytoskeleton reorganization and focal adhesion turnover (Louis and Zahradka, 2010, Canadian Journal of Physiology and Pharmacology). Therapeutic strategies often target specific components of this signaling network, such as using drug-eluting stents coated with Sirolimus or Paclitaxel to prevent neointimal hyperplasia (Stone et al., 2004, NEJM). While inhibiting VSMC migration is beneficial in preventing vessel narrowing, excessive inhibition can lead to impaired vascular healing and structural instability of the vessel wall (Shimokawa and Satoh, 2015, Journal of Cardiovascular Pharmacology).

Other names

VSMC migrationVascular smooth muscle cell chemotaxisSmooth muscle cell phenotypic switchingVSMC motility

Inhibition of specific signaling nodes (e.g., mTOR, ROCK, PDGFR) or cytoskeletal dynamics to prevent the transition of vascular smooth muscle cells from a contractile to a synthetic, migratory phenotype (Gerthoffer, 2007, Circulation Research; Stone et al., 2004, NEJM).